Arrowhead Research | ARWR - Trade Creditors


Arrowhead Research reported $32.94M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Agios Pharmaceuticals USD 18.36M 1.2M Dec/2025
Alnylam Pharmaceuticals USD 115.72M 1.87M Dec/2025
Anika Therapeutics USD 4.73M 39K Sep/2025
Arrowhead Research USD 32.94M 15.26M Dec/2025
Heron Therapeutics USD 12.02M 20K Sep/2025
Incyte USD 1.63B 1.46B Dec/2025
Ionis Pharmaceuticals USD 14.33M 8.47M Sep/2025
Ligand Pharmaceuticals USD 27.76M 1.72M Sep/2025
Merck USD 4.15B 102M Sep/2025
Moderna USD 317M 50M Dec/2025
Nektar Therapeutics USD 15.56M 1.28M Sep/2025
Novartis USD 4.56B 49M Sep/2025
Sarepta Therapeutics USD 94.02M 42.69M Sep/2025
TG Therapeutics USD 61.64M 72.38M Sep/2025
Ultragenyx Pharmaceutical USD 40.57M 6.33M Sep/2025
Vertex Pharmaceuticals USD 3.43B 600.9M Dec/2025
Xencor USD 10.83M 1.75M Dec/2025